BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33668286)

  • 1. Towards Personalised Contrast Injection: Artificial-Intelligence-Derived Body Composition and Liver Enhancement in Computed Tomography.
    de Jong DJ; Veldhuis WB; Wessels FJ; de Vos B; Moeskops P; Kok M
    J Pers Med; 2021 Feb; 11(3):. PubMed ID: 33668286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimal contrast dose indicator for the determination of hepatic enhancement in abdominal multidetector computed tomography: comparison of patient attenuation indicator with total body weight and body mass index.
    Li J; Udayasankar UK; Tang X; Carew J; Toth TL; Small WC
    J Comput Assist Tomogr; 2010; 34(6):874-8. PubMed ID: 21084903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic and hepatic enhancement at multidetector CT: evaluation of optimal iodine dose determined by lean body weight.
    Kondo H; Kanematsu M; Goshima S; Watanabe H; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Dec; 80(3):e273-7. PubMed ID: 21195572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
    Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
    AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT?
    Ho LM; Nelson RC; Delong DM
    Radiology; 2007 May; 243(2):431-7. PubMed ID: 17456869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individually Body Weight-Adapted Contrast Media Application in Computed Tomography Imaging of the Liver at 90 kVp.
    Martens B; Hendriks BMF; Eijsvoogel NG; Wildberger JE; Mihl C
    Invest Radiol; 2019 Mar; 54(3):177-182. PubMed ID: 30721159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective multicenter study on personalized and optimized MDCT contrast protocols: results on liver enhancement.
    Zanca F; Brat HG; Pujadas P; Racine D; Dufour B; Fournier D; Rizk B
    Eur Radiol; 2021 Nov; 31(11):8236-8245. PubMed ID: 33914115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast Material Injection Protocol With the Dose Determined According to Lean Body Weight at Hepatic Dynamic Computed Tomography: Comparison Among Patients With Different Body Mass Indices.
    Matsumoto Y; Masuda T; Sato T; Arataki K; Nakamura Y; Tatsugami F; Awai K
    J Comput Assist Tomogr; 2019; 43(5):736-740. PubMed ID: 31609293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing Iodinated Contrast Media According to Lean Versus Total Body Weight at Abdominal CT: A Stratified Randomized Controlled Trial.
    Costa AF; Peet K; Abdolell M
    Acad Radiol; 2020 Jun; 27(6):833-840. PubMed ID: 31439467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Contrast Media Application Based on Body Weight and Contrast Enhancement in Computed Tomography of Livers without Steatosis.
    de Jong DJ; van Cooten VV; Veldhuis WB; de Jong PA; Kok M
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight?
    Kondo H; Kanematsu M; Goshima S; Watanabe H; Kawada H; Moriyama N; Bae KT
    Eur Radiol; 2013 Jul; 23(7):1855-61. PubMed ID: 23508277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Enhancement on Computed Tomography Is Suboptimal in Patients with Liver Steatosis.
    van Cooten VV; de Jong DJ; Wessels FJ; de Jong PA; Kok M
    J Pers Med; 2021 Nov; 11(12):. PubMed ID: 34945727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume.
    Kondo H; Kanematsu M; Goshima S; Tomita Y; Kim MJ; Moriyama N; Onozuka M; Shiratori Y; Bae KT
    Radiology; 2010 Jan; 254(1):163-9. PubMed ID: 20019137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Contrast Dose Based in Lean body Weight Allow Lesser Volumes on High BMI Patients for CT Angiography?
    Chandrasekharan R; Kulkarni CB; Pullara SK; Moorthy S
    J Clin Imaging Sci; 2021; 11():38. PubMed ID: 34345528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aorta, liver, and portal vein CT contrast enhancement during the portal venous phase are positively associated with abdominal fat percentage in dogs.
    Kan J; Milne M
    Vet Radiol Ultrasound; 2021 Jul; 62(4):437-444. PubMed ID: 33567137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Cirrhotic Liver Enhancement With Multiphasic Computed Tomography Using a Faster Injection Rate, Late Arterial Phase, and Weight-Based Contrast Dosing.
    Eddy K; Costa AF
    Can Assoc Radiol J; 2017 Nov; 68(4):371-378. PubMed ID: 28720415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and Hepatic Contrast Enhancement During Hepatic-Arterial and Portal Venous Phase Computed Tomography Scanning: Multivariate Linear Regression Analysis Using Age, Sex, Total Body Weight, Height, and Cardiac Output.
    Masuda T; Nakaura T; Funama Y; Higaki T; Kiguchi M; Imada N; Sato T; Awai K
    J Comput Assist Tomogr; 2017; 41(2):309-314. PubMed ID: 27759599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lean body weight-adjusted intravenous iodinated contrast dose for abdominal CT in dogs reduces interpatient enhancement variability while providing diagnostic quality organ enhancement.
    Kan J; Milne M; Tyrrell D; Mansfield C
    Vet Radiol Ultrasound; 2022 Nov; 63(6):719-728. PubMed ID: 35687840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fatty infiltration on the liver tissue enhancement during portal phase computed tomography.
    Tsushima Y; Aoki J; Endo K
    Acad Radiol; 2003 Sep; 10(9):1008-12. PubMed ID: 13678089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.